<DOC>
	<DOCNO>NCT01508429</DOCNO>
	<brief_summary>Misoprostol , prostaglandin E1 induce uterine contraction , propose low cost , easy-to-use option prevention treatment Postpartum Haemorrhage ( PPH ) , especially setting injectable uterotonics yet available feasible use . A double-blinded individual randomize control study misoprostol versus placebo home delivery four district Badakshan Province Afghanistan . The study recruit pregnant woman likely deliver home . All woman enrol study receive 600 mcg misoprostol self-administered prophylaxis PPH delivery baby ( y ) delivery placenta . Women experience PPH randomize receive either : ) standard care + 800 mcg misoprostol ( four 200 mcg tablet ) b ) standard care + four placebo tablet resemble misoprostol . In set , standard care referral .</brief_summary>
	<brief_title>Misoprostol Treatment Postpartum Haemorrhage ( PPH ) Home Births</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Women must pregnant Must able provide inform consent Must agree community health worker present time delivery Must agree participate follow interview study midwife Must agree pre postpartum haemoglobin take Women meet inclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>PPH</keyword>
	<keyword>misoprostol</keyword>
	<keyword>home delivery</keyword>
</DOC>